Medical Research & Talent|November 20, 2020
At Whitehead Institute, Tobi Oni will focus on uncovering mechanisms for the poor anti-tumor immune response to pancreatic cancer, and work to develop novel ways of promoting tumor clearance by immune cells. And—following in his mother’s footsteps—he will pursue opportunities to inspire and mentor the next generation of scientists from diverse backgrounds.
Early Childhood Development|October 29, 2020
Waterford.org’s program will serve 2,500 preschool-aged children from Nov. 1 of this year to Feb. 5, 2021. The program will provide a laptop or internet access to any family that needs it, and children will receive an adjusted version of Waterford’s flagship at-home kindergarten readiness program, Waterford Upstart.
Early Childhood Development|October 20, 2020
The wraparound care provided by HealthySteps and Nurse-Family Partnership allows new mothers and their babies to thrive.
Valhalla Update|May 1, 2020
In March 2020, as COVID-19 began spreading rapidly, it became clear that the impacts of the pandemic would be severe and particularly devastating on the disadvantaged populations we seek to serve through our work at Valhalla Foundation. In response, we committed $15.6M to 14 organizations over the first few months of the pandemic.
Medical Research & Talent|March 28, 2017
The drug, ocrelizumab, is one of three new "B-cell" therapies to treat MS that have proven to be extremely effective in preventing MS relapses.